Home / Central Data Catalog / IMPACT_EVALUATION / BEN_2010_HRBF_V01_M_V01_A_PUF / variable [F44]
impact_evaluation

Health Results-Based Financing Impact Evaluation Survey 2010-2011, Baseline

Benin, 2010 - 2011
Get Microdata
Reference ID
BEN_2010_HRBF_v01_M_v01_A_PUF
DOI
https://doi.org/10.48529/qkmg-r734
Producer(s)
Christophe Lemière and Damien de Walque
Collection(s)
Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Oct 20, 2014
Last modified
Oct 21, 2014
Page views
524646
Downloads
15620

3.1. dosage (j1) (k3_3_1_j1_w)

Data file: benhrbf2_k3_1

Overview

Valid: 246
Invalid: 0
Type: Discrete
Start: 38
End: 66
Width: 29
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
0.2 MG 1
0.4%
0.5 MG INJ 1
0.4%
1 G 1
0.4%
1 G INJ 1
0.4%
10 1
0.4%
10 UI 1
0.4%
10 UI INJ 1
0.4%
10% 1
0.4%
100 MG 3
1.2%
100 MG COMPS 1
0.4%
100 MG CP 2
0.8%
100MG 11
4.5%
100MG COMP 2
0.8%
100MG COMPRIME 1
0.4%
100MG CP 3
1.2%
10MG 5
2%
10MG COMPRIMES 1
0.4%
10MG CP 1
0.4%
10ML 1
0.4%
10UI 1
0.4%
120MG 12CP 1
0.4%
120MG 18CP 2
0.8%
120MG 24CP 1
0.4%
120MG 6CP 1
0.4%
125 MG SIROP 1
0.4%
125MG FLACON 1
0.4%
125MG SIROP 3
1.2%
1G 5
2%
1G FLACON 2
0.8%
1G INJ 2
0.8%
1G/10ML 1
0.4%
2 ML 1
0.4%
20/120 BLISTER 24CP 1
0.4%
20/120MG BLISTER 6CP 1
0.4%
200 MG 2
0.8%
200/40MG 1
0.4%
200MG 9
3.7%
200MG COMP 1
0.4%
200MG CP 1
0.4%
200MG/12ML 1
0.4%
20MG 2
0.8%
20MG COMP 2
0.8%
20MG CP 1
0.4%
20MG/ 120MG 1
0.4%
20MG/120MG 1
0.4%
20MG/120MG BLISTER 12 1
0.4%
20MG/120MG BLISTER DE 12 COMP 1
0.4%
240MG SUSP FLACON 1
0.4%
25 MG 1
0.4%
250 MG 2
0.8%
250 MG SIROP 1
0.4%
250MG 9
3.7%
250MG FLACON 1
0.4%
250MG COMP 2
0.8%
250MG COMPRIMES 1
0.4%
250MG CP 2
0.8%
25MG 1
0.4%
2ML 1
0.4%
300 MG 1
0.4%
300 MG COMP 1
0.4%
300 MG COMPRIMES 1
0.4%
300 MG COMPS 1
0.4%
300MG 3
1.2%
300MG COMP 1
0.4%
300MG COMPRIMES 1
0.4%
300MG CP 2
0.8%
400 MG COMP 1
0.4%
400/80MG 1
0.4%
400MG 7
2.8%
400MG COMP 3
1.2%
400MG COMPRIME 1
0.4%
400MG CP 2
0.8%
400MG/80MG 1
0.4%
480 MG 1
0.4%
480MG 2
0.8%
480MG COMPRIMES 1
0.4%
48MG COMP 1
0.4%
5 MG 1
0.4%
5 MG INJ 2
0.8%
5 ML 1
0.4%
5 ML-CC 1
0.4%
5% 1
0.4%
5% 500CC FL 1
0.4%
5% 500ML 1
0.4%
50 MG 1
0.4%
500 CP 1
0.4%
500 MG 7
2.8%
500 MG AMP 1
0.4%
500 MG COMP 2
0.8%
500 MG COMPS 2
0.8%
500 MG CPRIME 1
0.4%
500 MG-25 MG 1
0.4%
500 ML 1
0.4%
50000UI 1
0.4%
500MG 33
13.4%
500MG 62.5MG COMP 1
0.4%
500MG COMP 4
1.6%
500MG COMPRIMES 8
3.3%
500MG CP 6
2.4%
500MG OVULE 1
0.4%
50MG 1
0.4%
5CC 1
0.4%
5MG 13
5.3%
5MG COMP 1
0.4%
5MG INJECTABLE 1
0.4%
600 MG INJ 1
0.4%
600MG 1
0.4%
80MG INJ 1
0.4%
9% 500ML 1
0.4%
AMP 80MG 1
0.4%
COMP 1
0.4%
COMPRIMES 1
0.4%
CP 2
0.8%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.